Health
SARS-CoV-2 anti-nucleocapsid antibodies reduce risk of reinfection for at least eight months – News-Medical.Net
A new study concludes that at least with predominantly wild-type variants, the risk of reinfection with the virus among unvaccinated…
As the coronavirus disease 2019 (COVID-19) pandemic continues to take a heavy toll on the world population, scientists are seeking to identify the protective impact of prior infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
…
Continue Reading
-
General18 hours agoCampers evacuated, residents on alert as Moreton Island bushfire intensifies
-
General23 hours agoAustralia welcomes Gaza peace progress, hostage release
-
General16 hours agoHundreds attend justice march for Kaiden Morgan-Johnston in Morwell
-
Noosa News24 hours agoHow Cairns startup Rainstick is using biotech to transform farming